Health Care · Pharmaceutical Preparations · NYSE · CIK 1837607 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $0.20 · Day −19.02% · Mkt cap $12M · 1Y −72.9% · Off 52W high −86.3% · Vol (1Y) 103.8% Price2023-08-21 → 2026-08-19 AEON close: $302 on 2023-08-21 to $0 on 2026-08-19. Split-adj closes · 240 of 767 · price returnⓘ At a glance | Short interest1.8% of sh out | | Days to cover1.0d | | 13F net flow (QoQ)+0.77% | | Top-10 13F concentration99.8% | | Next report (est.)2026-11-10 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−82.0% | | 1Y−72.9% | | 3Y−99.9% | | Since incept. (ann.)−92.9% |
Price return · from 2023-07-24ⓘ Risk | Ann. volatility (1Y)103.8% | | Ann. volatility (3Y)152.7% | | Sharpe (1Y)−0.77 | | Sharpe (3Y)−0.75 | | Max drawdown (1Y)−85.8% | | Max drawdown (3Y)−100.0% | | Beta (3Y vs SPY)1.99 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Dauntless Investment Group, LLC | 2.5M | $2M | 9.99% | +18.6% | | VANGUARD CAPITAL MANAGEMENT LLC | 90,529 | $89,171 | 0.36% | new | | GEODE CAPITAL MANAGEMENT, LLC | 87,062 | $85,755 | 0.34% | +44.8% | | Blue Owl Capital Holdings LP | 42,353 | $41,506 | 0.17% | −2.4% | | Formidable Asset Management, LLC | 20,024 | $22,026 | 0.08% | new | | XTX Topco Ltd | 20,424 | $20,118 | 0.08% | −64.1% | | JANE STREET GROUP, LLC | 16,376 | $16,130 | 0.06% | new | | VANGUARD FIDUCIARY TRUST CO | 14,702 | $14,481 | 0.06% | new |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-12 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-12 | −$0.02 | — | — | — | | 2026-03-31 | 2026-05-14 | −$0.29 | −112.7% | — | — | | 2025-09-30 | 2025-11-14 | −$0.39 | — | — | — | | 2025-06-30 | 2025-08-12 | −$0.60 | — | — | — |
As-reported XBRL · next 2026-11-10 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
